Objectives To examine the response to single-day intravenous pamidronate in a
heterogeneous population with symptomatic osteoporosis. Study design Patients (n= 18) 6 …

Despite the proven efficacy of low-dose Pamidronate in adults with osteoporosis, the efficacy
of the low-dose regimen in children has not been studied. Pamidronate (1 mg/kg) was …

AIMS To investigate the use of the aminobisphosphonate, disodium pamidronate, in children
with vertebral osteoporosis. METHODS Five children (aged 10–15 years) with vertebral …

Aim: To study the safety and efficacy of zole-dronic acid treatment in children with
ostcoporotic bone disorders. Study design: Observational study in 22 patients with …

Pediatric nephrology and rheumatology patients with steroid-induced osteopenia are at risk
of skeletal fracture. Bisphosphonate therapy has not been routinely advocated as a primary …

Objectives: To describe an attempted interventional trial for glucocorticoid‐induced
osteoporosis in children and adolescents and to discuss the reasons for trial failure to inform …

Oral bisphosphonates are an established mode of therapy for the prevention and treatment
of osteoporosis. However, many patients are unable to take them either because of poor …

Aim: To evaluate the safety and efficacy of 12 months of zoledronic acid (ZA) administered
every 6 months to children with osteoporosis. Methods: Retrospective cohort study of 27 …

The successful use of pamidronate, a bisphosphonate, for the treatment of hypercalcemia
and/or osteopenia is reported in three children with renal failure or following renal …

Although spontaneous remission occurs in patients with idiopathic juvenile osteoporosis
(IJO), permanent bone deformities may occur. The effects of long-term pamidronate …